IDEAYA BIOSCIENCES INC's ticker is IDYA and the CUSIP is 45166A102. A total of 98 filers reported holding IDEAYA BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,525,314 | +617.3% | 56,535 | +524.8% | 0.00% | – |
| Q2 2023 | $212,652 | -72.6% | 9,049 | -84.0% | 0.00% | – |
| Q1 2023 | $775,113 | -62.8% | 56,454 | -50.7% | 0.00% | -100.0% |
| Q4 2022 | $2,082,337 | +838.0% | 114,603 | +671.7% | 0.00% | – |
| Q3 2022 | $222,000 | +246.9% | 14,850 | +222.4% | 0.00% | – |
| Q2 2022 | $64,000 | -92.5% | 4,606 | -94.0% | 0.00% | – |
| Q1 2022 | $854,000 | -69.2% | 76,371 | -34.9% | 0.00% | -100.0% |
| Q4 2021 | $2,774,000 | +145.3% | 117,367 | +164.5% | 0.00% | – |
| Q3 2021 | $1,131,000 | +132.2% | 44,371 | +91.2% | 0.00% | – |
| Q2 2021 | $487,000 | +67.4% | 23,211 | +87.7% | 0.00% | – |
| Q1 2021 | $291,000 | +2325.0% | 12,365 | +1339.5% | 0.00% | – |
| Q4 2020 | $12,000 | +300.0% | 859 | +232.9% | 0.00% | – |
| Q3 2020 | $3,000 | -94.4% | 258 | -93.2% | 0.00% | – |
| Q2 2020 | $54,000 | +1700.0% | 3,815 | +443.4% | 0.00% | – |
| Q1 2020 | $3,000 | -88.9% | 702 | -76.8% | 0.00% | – |
| Q3 2019 | $27,000 | – | 3,023 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners X LLC | 2,660,713 | $29,774,000 | 30.23% |
| Logos Global Management LP | 2,850,000 | $31,892,000 | 4.14% |
| 5AM Venture Management, LLC | 1,398,066 | $15,644,000 | 3.42% |
| ACT CAPITAL MANAGEMENT, LLC | 173,500 | $1,941,000 | 2.05% |
| DAFNA Capital Management LLC | 490,061 | $5,484,000 | 1.43% |
| Boxer Capital, LLC | 2,202,812 | $24,649,000 | 1.27% |
| BVF INC/IL | 1,600,559 | $17,910,000 | 0.72% |
| Avidity Partners Management LP | 2,690,000 | $30,101,000 | 0.63% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 62,929 | $704,000 | 0.43% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 109,000 | $1,623,000 | 0.37% |